Rapamycin: Personal algorithms for use based on 250 treated renal allograft recipients

被引:29
作者
Kahan, BD [1 ]
机构
[1] Univ Texas, Sch Med, Dept Surg, Div Organ Transplantat, Houston, TX 77030 USA
关键词
D O I
10.1016/S0041-1345(98)00585-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:2185 / 2188
页数:4
相关论文
共 16 条
[1]   THE INFLUENCE OF PRETRANSPLANT LIPOPROTEIN ABNORMALITIES ON THE EARLY RESULTS OF RENAL-TRANSPLANTATION [J].
DIMENY, E ;
TUFVESON, G ;
LITHELL, H ;
LARSSON, E ;
SIEGBAHN, A ;
FELLSTROM, B .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1993, 23 (09) :572-579
[2]  
DIMENY E, 1993, TRANSPLANT P, V25, P2065
[3]   THE IMPACT OF STEADY-STATE CYCLOSPORINE CONCENTRATIONS ON RENAL-ALLOGRAFT OUTCOME [J].
DUNN, J ;
GREVEL, J ;
NAPOLI, K ;
LEWIS, RM ;
VANBUREN, CT ;
KAHAN, BD .
TRANSPLANTATION, 1990, 49 (01) :30-34
[4]  
GROTH CG, 1997, 23 ANN SCI M AM SOC, pA223
[6]   Sirolimus: A new agent for clinical renal transplantation [J].
Kahan, BD .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :48-50
[7]  
KAHAN BD, 1989, NEW ENGL J MED, V321, P1725
[8]   DEMOGRAPHIC-FACTORS AFFECTING THE PHARMACOKINETICS OF CYCLOSPORINE ESTIMATED BY RADIOIMMUNOASSAY [J].
KAHAN, BD ;
KRAMER, WG ;
WIDEMAN, C ;
FLECHNER, SM ;
LORBER, MI ;
VANBUREN, CT .
TRANSPLANTATION, 1986, 41 (04) :459-464
[9]   SYNERGISTIC INTERACTIONS OF CYCLOSPORINE AND RAPAMYCIN TO INHIBIT IMMUNE PERFORMANCES OF NORMAL HUMAN PERIPHERAL-BLOOD LYMPHOCYTES INVITRO [J].
KAHAN, BD ;
GIBBONS, S ;
TEJPAL, N ;
STEPKOWSKI, SM ;
CHOU, TC .
TRANSPLANTATION, 1991, 51 (01) :232-239
[10]  
KAHAN BD, 1998, GRAFT S2, V1, P93